Free Trial

Treace Medical Concepts Q2 2024 Earnings Report

Treace Medical Concepts logo
$9.27 +0.56 (+6.43%)
As of 04:00 PM Eastern

Treace Medical Concepts EPS Results

Actual EPS
-$0.34
Consensus EPS
-$0.29
Beat/Miss
Missed by -$0.05
One Year Ago EPS
-$0.20

Treace Medical Concepts Revenue Results

Actual Revenue
$44.46 million
Expected Revenue
$43.00 million
Beat/Miss
Beat by +$1.46 million
YoY Revenue Growth
+6.00%

Treace Medical Concepts Announcement Details

Quarter
Q2 2024
Time
After Market Closes

Conference Call Resources

Conference Call Audio

Treace Medical Concepts Earnings Headlines

2025: Crypto Opportunities You Can’t Afford to Miss
Cryptocurrencies are once again gaining incredible momentum, and savvy investors are positioning themselves to capitalize on this surge in 2025. The question is—will you be among them? With groundbreaking advancements and increasing institutional adoption on the horizon, there's never been a better time to explore the potential gains in crypto. What’s Fueling the Crypto Comeback?
Lake Street Sticks to Its Buy Rating for Treace Medical Concepts (TMCI)
Treace Medical Concepts (TMCI) Receives a Hold from Stifel Nicolaus
Treace Medical Preliminary Q4, FY24 Revenues Beat Expectations; Stock Up
See More Treace Medical Concepts Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Treace Medical Concepts? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Treace Medical Concepts and other key companies, straight to your email.

About Treace Medical Concepts

Treace Medical Concepts (NASDAQ:TMCI), a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.

View Treace Medical Concepts Profile

More Earnings Resources from MarketBeat